Figure 4. Gel showing the PCR product of BRCA1 exons 3 (above) and exons 5 (bottom). Sample B2 and N5 are missing exon 3 and exon 5 while samples N4 and N5 are missing exon 5 but not exon 3

From

The Prediagnosis of Prostate Cancer Risk is Possible with the Evaluation of BRCA1 Primary Exons in Men

Haboubacar Elhadji Yaou Moussa, Maazou Halidou, Sara Y. Houngue, Josué Avakoudjo, Solomon Oladapo Rotimi, Callinice D. Capo-Chichi

American Journal of Cancer Prevention. 2023, 10(1), 14-20 doi:10.12691/ajcp-10-1-4